Beijing Aosaikang Pharmaceutical Co., Ltd. (SZSE: 002755)
Health Care · Pharmaceuticals · CN
CN¥12.91
-6.04% today · -49.4% 1Y
Beijing Aosaikang Pharmaceutical Co., Ltd. (SZSE: 002755) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.78B and employs 799 people.
Over the last twelve months the share price has lost 49.4%, trading between 12.06 and 25.75.
Tweenvest scores Beijing Aosaikang Pharmaceutical Co., Ltd. across four factors: quality 72/100, value 38/100, growth 0/100, dividend 49/100. Its strongest factor is quality.
002755 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.78B
- Revenue (TTM)
- $254.05M
- P/E
- 46.19
- EPS
- 0.28
- Dividend yield
- 0.93%
- Beta (5Y)
- 0.11
- 52-week high
- CN¥25.75
- 52-week low
- CN¥12.06
- Avg volume (3M)
- —
- Shares outstanding
- 928.16M
- Employees
- 799
- Next earnings
- —
About Beijing Aosaikang Pharmaceutical Co., Ltd.
Operating within China, Beijing Aosaikang Pharmaceutical Co., Ltd. specializes in the research, development, production, and sale of pharmaceuticals, fine chemicals, and health products. Its diverse offerings include proton pump inhibitor injections, oncology medications, and active pharmaceutical ingredients (APIs), which are applied across key therapeutic areas like digestive disorders, cancer treatment, and infectious diseases. The company was founded in 2003 and is headquartered in Nanjing, China.
- ISIN
- CNE100001X92
- Founded
- 1996
- Listed since
- May 15, 2015
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,242.49 | -1.03% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.72 | +1.29% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.81 | -1.14% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.00 | -0.27% |
Figures last refreshed Aug 18, 2026.